Miramax, an American entertainment and production company, has filed a lawsuit against Quentin Tarantino over the director’s plans to create and auction off a series of Non-Fungible Tokens (NFTs) based on his work on the 1994 movie “Pulp Fiction”.
Tarantino recently announced his plans to sell seven NFTs related to his work. They are planned to go on sale next month, including blockchain tokens of scanned digital copies of handwritten script pages for uncut scenes of the film, with audio commentary, and each containing a “secret” element accessible only to the owner. According to the lawsuit, the planned offerings through the NFTs violate the copyrights that the entertainment company holds to the director’s film and that the NFTs don’t fall under Tarantino’s reserved rights for the film.
The Delhi High Court had recently granted an ex parte ad interim injunction to Britannia Industries against Good Day Oral Care, an oral care seller, for allegedly using its identical trademark “Good Day.”
It was argued by Britannia Industries that the oral care company had used the mark, and opened a domain website for the selling of products with the impugned mark of ‘Good Day.’ This, they claimed, infringed upon Britannia’s well-known trademark- with the oral care products passing off as those of Britannia Industries’ products and causing confusion to the consumers. The oral care company, on the other hand, submitted that the “Good Day” mark was a generic mark which cannot be monopolized by the plaintiff.
The injunction has been passed against the oral care seller and others from launching, selling, manufacturing, advertising, offering for sale or in any manner dealing in goods, bearing the impugned mark “Good Day” being deceptively similar to Britannia’s trademark.
Vaccine production company Pfizer Inc. has signed a vaccine licensing agreement for Covid-19 oral antiviral treatment with the United Nations-backed public health organization Medical Patent Pool (MPP) the works on increasing access to life-saving medicines to low and middle-income countries. This voluntary agreement will help facilitate the additional production, distribution etc of the orally administered antiviral – that is presently in its investigational stage.
MPP can now grant sub-licenses to qualified genetic medicine manufacturers and facilitate greater access of the vaccine to the global population. The outreach of the same will be to around 95 countries, covering approximately 53% of the world population.
A Texas federal jury held that California based Google, and its video streaming platform – Youtube owes $26 million for a case of infringement of patent rights owned by VideoShare LLC.
The issue was regarding the technology used by Youtube to convert videos to multiple formats and ultimately transmit them in the most suitable form for the user’s device. Google contended the same was nothing but the conventional way of going about the procedure. However, the jury rejected the claim and considered it an infringement of VideoShare’s patented technology.
Google went on to raise allegations of how the patent in itself was invalid due to its abstract nature and argued that VideoShare obtained the said patent by withholding information from the US Patent and Trademark Office.
American Skateboarding-shoe maker Vans sued Walmart in California federal court for allegedly infringing its trademarks by selling copycat versions of more than 20 versions of its shoes. In its complaint, Vans has claimed that Walmart’s inhouse labels “Time and True”, “Wonder Nation” and “No Boundaries” have introduced cheap, low-quality shoes which are confusingly similar and knock off versions of Vans shoes. Vans has accused Walmart of a deceptive marketing campaign which creates a misleading impression that its shoes are associated with its products. The complaint details that Walmart’s alleged intentional marketing of its infringing shoes as ‘Skate’ or ‘Retro’ sneakers suggests its connection with Vans’ products. Thus, Vans has alleged a wilful infringement of trademark rights via a concerted campaign to copy Vans’ best-selling shoes.
Sportswear titan Nike has filed seven new intent-to-use applications with the U.S. Patent and Trademark Office in an effort towards its transition to the Metaverse. These applications were made for its most popular trademarks including word marks- “Nike”, “Just Do It”, “Jordan” and “Air Jordan”. Applications were also filed for the iconic swoosh logo, the Jordan silhouette logo, and a stylized combination of its name and the swoosh for use on several virtual services. The applications detail Nike’s plans to use the patents for “downloadable virtual goods, retail store services featuring virtual goods and entertainment services”. The metaverse refers to a virtual reality space wherein the users can interact with others within a computer-generated environment. Making the most of the opportunities offered by the metaverse, Nike has been observed to be excited to engage with consumers the virtual way. Recently, Nike has also teamed up with online game platform Roblox for ‘Nikeland’ a digital experience enabling consumers to connect, compete and shop.
The Irish Government has signed the European Directive on Copyright in the Digital Single Market into law. This move comes five months after the deadline set by the European Commission, which adopted the directive two years ago after a three-year negotiating period. This law is said to strengthen the rights of copyright holders such as authors, journalists and other creators. It entails online platforms like Google and Facebook to negotiate financial agreements with media organisations when sharing their content online. Without an agreement, platforms will still be able to use hyperlinks or short extracts. Therefore, the legislation aims to level the playing field between the creative industries and tech platforms. The former will now have a right to appropriate remuneration and a transparency obligation over how their work will be used, thereby strengthening their position when making copyright agreements.
GlaxoSmithKline, the British drugmaker, has filed a patent infringement action against Glenmark in the Delhi High Court. GSK has alleged that Glenmark’s Vilor F medicine infringes the Indian patent of GSK for Vilanterol, an active ingredient. Vilor F is used to prevent and decrease symptoms caused by ongoing lung diseases such as asthma and chronic bronchitis. It has two active ingredients – fluticasone furoate, a corticosteroid, and vilanterol, a long-acting Beta-2 agonist invented by GSK in 2001. The patent for vilanterol in India was granted to GSK in 2007 which is set to expire in September 2022. “GSK seeks to rely on the intellectual property laws to protect its inventions as it deems appropriate for each situation,” a company spokesperson for GSK said. “At present this is the only known infringement of GSK’s patents covering vilanterol,” the person said.
3) Pfizer By: Pfizer
4) Reuters By: Shannon Stapleton